These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4360237)

  • 21. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
    [No Abstract]   [Full Text] [Related]  

  • 22. [Will Salk's polio vaccination be used again?].
    Stickl H
    Fortschr Med; 1978 Apr; 96(13):688-94. PubMed ID: 631710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poliovirus vaccines: live or dead.
    Ogra PL; Faden HS
    J Pediatr; 1986 Jun; 108(6):1031-3. PubMed ID: 3712146
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of Sabin poliovirus vaccine on incidence of poliomyelitis in Italy.
    Giovanardi A
    JAMA; 1969 Jul; 209(4):525-8. PubMed ID: 4307421
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaccination against poliomyelitis in Canada.
    Can J Public Health; 1967 Oct; 58(10):467-8. PubMed ID: 6079742
    [No Abstract]   [Full Text] [Related]  

  • 28. On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine.
    Peng X; Hu X; Salazar MA
    Lancet; 2018 Aug; 392(10147):610-612. PubMed ID: 29605427
    [No Abstract]   [Full Text] [Related]  

  • 29. Reassessment of the place of inactivated poliomyelitis vaccine in national immunization programmes.
    Assaad F
    Dev Biol Stand; 1981; 47():275-82. PubMed ID: 6262152
    [No Abstract]   [Full Text] [Related]  

  • 30. Killed polio virus vaccine in the control of poliomyelitis in Finland.
    Lapinleimu K
    Ann Clin Res; 1982 Dec; 14(5-6):199-203. PubMed ID: 6303196
    [No Abstract]   [Full Text] [Related]  

  • 31. World could be declared free of polio by 2018.
    Gulland A
    BMJ; 2013 Apr; 346():f2373. PubMed ID: 23585234
    [No Abstract]   [Full Text] [Related]  

  • 32. Polio eradication in India: how far are we from reaching the goal?
    Banerjee K; Sahu S; Bandyopadhyay S
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S6-14. PubMed ID: 11411387
    [No Abstract]   [Full Text] [Related]  

  • 33. [Open season on poliovirus].
    Kapsenberg JG
    Ned Tijdschr Geneeskd; 1989 Apr; 133(17):864-6. PubMed ID: 2725744
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 35. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined use of live and killed vaccines to control poliomyelitis in tropical areas.
    Melnick JL
    Dev Biol Stand; 1981; 47():265-73. PubMed ID: 7227655
    [No Abstract]   [Full Text] [Related]  

  • 37. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 38. Poliomyelitis vaccines: an appraisal after 25 years.
    Melnick JL
    Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccine-derived poliovirus cases exceed wild types.
    Burki T
    Lancet Infect Dis; 2019 Feb; 19(2):140. PubMed ID: 31876508
    [No Abstract]   [Full Text] [Related]  

  • 40. [The perspective of global eradication of poliomyelitis].
    Windorfer A
    Gesundheitswesen; 2004; 66(8-9):553-4; athor reply 554. PubMed ID: 15478288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.